Mäkelä Sanna M, Österlund Pamela, Westenius Veera, Latvala Sinikka, Diamond Michael S, Gale Michael, Julkunen Ilkka
Viral Infections Unit, Department of Infectious Diseases, National Institute for Health and Welfare, Helsinki, Finland
Viral Infections Unit, Department of Infectious Diseases, National Institute for Health and Welfare, Helsinki, Finland.
J Virol. 2015 Dec;89(23):12014-25. doi: 10.1128/JVI.01576-15. Epub 2015 Sep 16.
Influenza B virus causes annual epidemics and, along with influenza A virus, accounts for substantial disease and economic burden throughout the world. Influenza B virus infects only humans and some marine mammals and is not responsible for pandemics, possibly due to a very low frequency of reassortment and a lower evolutionary rate than that of influenza A virus. Influenza B virus has been less studied than influenza A virus, and thus, a comparison of influenza A and B virus infection mechanisms may provide new insight into virus-host interactions. Here we analyzed the early events in influenza B virus infection and interferon (IFN) gene expression in human monocyte-derived macrophages and dendritic cells. We show that influenza B virus induces IFN regulatory factor 3 (IRF3) activation and IFN-λ1 gene expression with faster kinetics than does influenza A virus, without a requirement for viral protein synthesis or replication. Influenza B virus-induced activation of IRF3 required the fusion of viral and endosomal membranes, and nuclear accumulation of IRF3 and viral NP occurred concurrently. In comparison, immediate early IRF3 activation was not observed in influenza A virus-infected macrophages. Experiments with RIG-I-, MDA5-, and RIG-I/MDA5-deficient mouse fibroblasts showed that RIG-I is the critical pattern recognition receptor needed for the influenza B virus-induced activation of IRF3. Our results show that innate immune mechanisms are activated immediately after influenza B virus entry through the endocytic pathway, whereas influenza A virus avoids early IRF3 activation and IFN gene induction.
Recently, a great deal of interest has been paid to identifying the ligands for RIG-I under conditions of natural infection, as many previous studies have been based on transfection of cells with different types of viral or synthetic RNA structures. We shed light on this question by analyzing the earliest step in innate immune recognition of influenza B virus by human macrophages. We show that influenza B virus induces IRF3 activation, leading to IFN gene expression after viral RNPs (vRNPs) are released into the cytosol and are recognized by RIG-I receptor, meaning that the incoming influenza B virus is already able to activate IFN gene expression. In contrast, influenza A (H3N2) virus failed to activate IRF3 at very early times of infection, suggesting that there are differences in innate immune recognition between influenza A and B viruses.
乙型流感病毒每年都会引发疫情,与甲型流感病毒一起,在全球范围内造成了巨大的疾病负担和经济负担。乙型流感病毒仅感染人类和一些海洋哺乳动物,不会引发大流行,这可能是由于其基因重配频率极低,且进化速率低于甲型流感病毒。与甲型流感病毒相比,乙型流感病毒的研究较少,因此,比较甲型和乙型流感病毒的感染机制可能会为病毒-宿主相互作用提供新的见解。在这里,我们分析了乙型流感病毒感染人类单核细胞衍生的巨噬细胞和树突状细胞的早期事件以及干扰素(IFN)基因表达。我们发现,乙型流感病毒诱导干扰素调节因子3(IRF3)激活和IFN-λ1基因表达的动力学比甲型流感病毒更快,且无需病毒蛋白合成或复制。乙型流感病毒诱导的IRF3激活需要病毒膜与内体膜融合,并且IRF3和病毒核蛋白(NP)的核积累同时发生。相比之下,在甲型流感病毒感染的巨噬细胞中未观察到早期IRF3激活。对RIG-I、MDA5和RIG-I/MDA5缺陷型小鼠成纤维细胞的实验表明,RIG-I是乙型流感病毒诱导IRF3激活所需的关键模式识别受体。我们的结果表明,在乙型流感病毒通过内吞途径进入后,先天免疫机制立即被激活,而甲型流感病毒则避免早期IRF3激活和IFN基因诱导。
最近,人们对在自然感染条件下识别RIG-I的配体产生了浓厚兴趣,因为许多先前的研究都是基于用不同类型的病毒或合成RNA结构转染细胞。通过分析人类巨噬细胞对乙型流感病毒先天免疫识别的最早步骤,我们阐明了这个问题。我们发现,乙型流感病毒诱导IRF3激活,导致病毒核糖核蛋白(vRNP)释放到细胞质中并被RIG-I受体识别后IFN基因表达,这意味着进入的乙型流感病毒已经能够激活IFN基因表达。相比之下,甲型(H3N2)流感病毒在感染的早期未能激活IRF3,这表明甲型和乙型流感病毒在先天免疫识别方面存在差异。